ILA 1660.0
(-3.54%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 93.55 Million USD | -12.41% |
2022 | 106.81 Million USD | 23.19% |
2021 | 86.7 Million USD | 8.43% |
2020 | 79.96 Million USD | 48.59% |
2019 | 53.81 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 86.79 Million USD | -2.7% |
2024 Q1 | 89.2 Million USD | -4.65% |
2023 FY | 93.55 Million USD | -12.41% |
2023 Q1 | 93.64 Million USD | -12.33% |
2023 Q3 | 101.52 Million USD | 8.87% |
2023 Q4 | 93.55 Million USD | -7.85% |
2023 Q2 | 93.24 Million USD | -0.43% |
2022 Q3 | 103.21 Million USD | -12.12% |
2022 Q2 | 117.44 Million USD | 0.0% |
2022 FY | 106.81 Million USD | 23.19% |
2022 Q4 | 106.81 Million USD | 3.49% |
2021 Q2 | 76.17 Million USD | 0.0% |
2021 FY | 86.7 Million USD | 8.43% |
2021 Q4 | 86.7 Million USD | 0.0% |
2020 FY | 79.96 Million USD | 48.59% |
2020 Q4 | 79.96 Million USD | 0.0% |
2019 FY | 53.81 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
C-Lab Ltd | 3.62 Billion ILA | 97.419% |